SeaStar Medical Fourth Quarter and Year-End 2024 Financial Results Conference Call A replay of the call will be available after 7:30 pm ET and can be accessed as follows: The webcast replay is ...

Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8M First-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical Markets ...

Palantir Technologies (NASDAQ: PLTR) has been one of the best-performing stocks of the artificial intelligence (AI) era. Even ...

Canopy Growth Corporation’s (NASDAQ:CGC) free cash flow for Q3 2025 was an outflow of around $19.52 million, an improvement of 17% compared to the prior year. To help bolster its balance sheet, the ...

Elutia Inc. (Nasdaq: ELUT) ("Elutia” or the "Company”), a pioneer in drug-eluting biomatrix products, announced that it has entered into an agreement with Advantus Health Partners ("Advantus”), to ...

"Our strong fourth quarter performance reflects our continued progress in establishing Focal One Robotic HIFU as a mainstream treatment option for the management of prostate cancer,” said Ryan Rhodes, ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure ...

AUSTIN, Texas, March 27, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today unaudited consolidated financial results for the fourth quarter and full ...

We recently published a list of 15 Dividend Zombies to Invest in. In this article, we are going to take a look at where ...

Pulse Biosciences, Inc. ( NASDAQ: PLSE) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Philip Trip Taylor - Investor Relations Paul LaViolette - Chief Executive Officer and Co-Chairman of ...

AlloSource, a life sciences organization that helps restore patient functionality by transforming the gift of human tissue ...

Private equity firm KKR is nearing a deal to acquire Japanese medical gear maker Topcon , according to people familiar with ...